Malladi Specialities Profile
Key Indicators
- Authorised Capital ₹ 19.00 Cr
as on 02-11-2024
- Paid Up Capital ₹ 18.64 Cr
as on 02-11-2024
- Company Age 35 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 15.36 Cr
as on 02-11-2024
- Revenue 4560.90%
(FY 2023)
- Profit 35910.52%
(FY 2023)
- Ebitda 11.01%
(FY 2023)
- Net Worth 201.73%
(FY 2023)
- Total Assets 224.92%
(FY 2023)
About Malladi Specialities
The Corporate was formerly known as Lactochem Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 19.00 Cr and a paid-up capital of Rs 18.64 Cr.
The company has closed loans amounting to ₹15.36 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Prashant Malladi, Shreya Sistla, and Ashray Sistla serve as directors at the Company.
- CIN/LLPIN
U24117TN1989PLC017845
- Company No.
017845
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
04 Aug 1989
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Malladi Specialities?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashant Malladi  | Director | 20-Sep-1990 | Current |
| Shreya Sistla | Director | 14-Sep-1991 | Current |
| Ashray Sistla | Director | 22-Jun-2017 | Current |
Financial Performance and Corporate Structure Insights of Malladi Specialities.
Malladi Specialities Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 4560.9% increase. The company also saw a substantial improvement in profitability, with a 35910.52% increase in profit. The company's net worth Soared by an impressive increase of 201.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Malladi Specialities?
In 2023, Malladi Specialities had a promoter holding of 89.63% and a public holding of 10.37%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Malladi Drugs And Pharmaceuticals LimitedActive 44 years 4 monthsPrashant Malladi and Shreya Sistla are mutual person
Tantech Agro Chemicals LimitedActive 35 years 2 monthsPrashant Malladi and Shreya Sistla are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 04 Mar 2005 | ₹0.40 M | Satisfied |
Canara Bank Creation Date: 07 Dec 2001 | ₹1.50 M | Satisfied |
Canara Bank Creation Date: 25 Jan 2001 | ₹1.75 Cr | Satisfied |
How Many Employees Work at Malladi Specialities?
Malladi Specialities has a workforce of 1 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Malladi Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Malladi Specialities's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
